These data emphasize the discrepancy in the clinical significance of tumor-associated vs. soluble plasma Arg-1 and suggest the existence of an unknown factor(s) that independently regulates Arg-1 levels in tumor cells and in plasma. The gene discussed is ARG1; the disease is neoplasm.